Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities:
Net income	$ 234,579	$ 142,407	$ 329,541
Adjustments to reconcile net income to net cash provided by operating activities, net of acquired businesses:
Depreciation and amortization	132,328	128,168	122,225
Deferred income taxes	31,040	7,583	(99,306)
Loss (gain) on disposition of assets	1,137	(1,131)	1,377
Share-based compensation	28,588	17,593	17,370
Excess tax benefit from share-based compensation	(2,309)	0	0
Non-cash interest expense	2,180	8,500	19,149
Non-cash reduction in contingent liabilities	0	(22,100)	0
(Increase) decrease in:
Receivables, net	(114,354)	(114,847)	(50,709)
Inventories	(67,400)	(72,810)	(36,725)
Other current assets	10,391	(46,695)	(84,866)
Pre-production and development costs	7,821	(23,708)	(18,624)
Increase (decrease) in:
Accounts payable	147,994	(23,394)	62,046
Accrued warranties	21,061	28,723	(10,348)
Accrued other liabilities	127,950	12,558	2,914
Income taxes payable	12,609	(3,026)	3,596
Net change in derivative assets and liabilities	18,121	(562)	(5,740)
Other operating activities	404	4,877	16,607
Net cash provided by operating activities	592,140	42,136	268,507
Cash flows from investing activities:
Acquisitions, net of cash received	(422,953)	(104,735)	(70,535)
Capital expenditures	(157,141)	(101,682)	(112,536)
Purchases of short-term investments	0	(73,761)	(559,283)
Maturities of short-term investments	10,008	267,278	673,591
Proceeds from asset dispositions	0	3,944	2,865
Purchase of investments for irrevocable trust	(42,400)	0	0
Other items, net	434	(1,735)	1,247
Net cash used in investing activities	(612,052)	(10,691)	(64,651)
Cash flows from financing activities:
Decrease in short-term borrowings	(1,162)	(36,590)	(1,308)
Borrowings under new credit agreement	300,000	300,000	0
Repayments of long-term debt	(30,000)	(424,079)	0
Debt issuance costs	0	(6,094)	0
Cash dividends to shareholders	(83,053)	(41,449)	(21,161)
Repurchase of common stock	(90,779)	(5,398)	(123,946)
Share-based payment arrangements, net of shares received	38,672	13,939	11,342
Excess tax benefit from share-based compensation	2,309	0	0
Other items, net	617	(3,740)	(12,573)
Net cash provided by (used in) financing activities	136,604	(203,411)	(147,646)
Effect of exchange rate changes on cash	10,362	8,868	(42,746)
Net increase (decrease) in cash and cash equivalents	127,054	(163,098)	13,464
Cash and cash equivalents at beginning of period	454,258	617,356	603,892
Cash and cash equivalents at end of period	581,312	454,258	617,356
Supplemental Disclosure of Cash Flow Information:
Accrued and contingent acquisition-related liabilities	$ 7,279	$ 288	$ 28,017